Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson’s Disease

Overview of attention for article published in Drug Safety, October 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Diagnosis and pharmacological management of Parkinson’s disease

Cited by Scottish Intercollegiate Guidelines Network on 18 Dec 2009

The Scottish Intercollegiate Guidelines Network (SIGN) develops evidence based clinical practice guidelines for the National Health Service (NHS) in Scotland.